<p><b>(A, B)</b> BT-549 cells and MDA—MB 231 were seeded in the Matrigel-coated upper compartment of Boyden chambers and incubated with DMSO or 100nM nilotinib for 24h before fixation. Cell nuclei in the lower chamber were stained with Hoechst (representative images in left panels, scale bar: 500μm. Insets show higher magnification of the boxed region) to quantify in whole well the number of cells that migrated from the top chamber through the Matrigel-coated filter pores. Shown is the cell invasion (mean ± SD, n = 3 experiments, right panels) relative to control (DMSO); *p<0.05 compared to control cells. <b>(C)</b> Cells were seeded in the upper compartment of Boyden chambers and incubated with DMSO or 100nM nilotinib for 45 min; quantific...
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>PC-3, DU-145, and CDXR-3 cells were pre-treated with 0, 10, or 20 µM triol for 48 hrs. Cells were...
<p>Synovial sarcoma SW982 and leiomyosarcoma SK-UT-1 cells were incubated with vehicle (DMSO) or DXR...
<p><b>(A, B)</b> Effect of nilotinib on BT-549 and MDA-MB 231 cell area. The area of 100 BT-549 (A) ...
<p>Anchorage-independent growth in soft agar was inhibited in the presence of nilotinib. (A) Visual ...
<p>Inhibition of tumour migration by a Boyden chamber assay. CaCo-2, HT29 and SW480 cells were plate...
<p>(A) DMSO decreases cancer cell migration ability, as assessed by a scratch wound healing assay. T...
<p>Cell monolayers were scratched with a pipette tip to produce a clear cell-free area into which ce...
<p>Cells were maintained in supplemented medium for 12 h, and then incubated with nilotinib (0∼100 µ...
<p><b>A</b>, RT-PCR for MDM2 mRNA expression in SUP-B15 cells, treated with 2 µM nilotinib and 0.2 µ...
<p>Cells were pre-treated with vehicle or nilotinib for 24 h, and DXR (0.05 µM) was then added to th...
<p>HEI-193 cells grown in PDGF-BB or GM were evaluated after 5 days of treatment with 0, 3, 5, 10 or...
Transwell assays were performed to assess the migration of (A) S2-013, (B) BxPC-3, (C) MIA PaCa-2, (...
Background: The availability of tyrosine kinase inhibitors (TKIs) has considerably changed the manag...
<p>The migration of HepG2/C3A and <b>PLC/PRF/5</b> cells was assayed using the Boyden chamber techni...
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>PC-3, DU-145, and CDXR-3 cells were pre-treated with 0, 10, or 20 µM triol for 48 hrs. Cells were...
<p>Synovial sarcoma SW982 and leiomyosarcoma SK-UT-1 cells were incubated with vehicle (DMSO) or DXR...
<p><b>(A, B)</b> Effect of nilotinib on BT-549 and MDA-MB 231 cell area. The area of 100 BT-549 (A) ...
<p>Anchorage-independent growth in soft agar was inhibited in the presence of nilotinib. (A) Visual ...
<p>Inhibition of tumour migration by a Boyden chamber assay. CaCo-2, HT29 and SW480 cells were plate...
<p>(A) DMSO decreases cancer cell migration ability, as assessed by a scratch wound healing assay. T...
<p>Cell monolayers were scratched with a pipette tip to produce a clear cell-free area into which ce...
<p>Cells were maintained in supplemented medium for 12 h, and then incubated with nilotinib (0∼100 µ...
<p><b>A</b>, RT-PCR for MDM2 mRNA expression in SUP-B15 cells, treated with 2 µM nilotinib and 0.2 µ...
<p>Cells were pre-treated with vehicle or nilotinib for 24 h, and DXR (0.05 µM) was then added to th...
<p>HEI-193 cells grown in PDGF-BB or GM were evaluated after 5 days of treatment with 0, 3, 5, 10 or...
Transwell assays were performed to assess the migration of (A) S2-013, (B) BxPC-3, (C) MIA PaCa-2, (...
Background: The availability of tyrosine kinase inhibitors (TKIs) has considerably changed the manag...
<p>The migration of HepG2/C3A and <b>PLC/PRF/5</b> cells was assayed using the Boyden chamber techni...
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>PC-3, DU-145, and CDXR-3 cells were pre-treated with 0, 10, or 20 µM triol for 48 hrs. Cells were...
<p>Synovial sarcoma SW982 and leiomyosarcoma SK-UT-1 cells were incubated with vehicle (DMSO) or DXR...